Xiaohong Qiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiaohong Qiao has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Shuanglong Lu
Department of Pediatrics, Tongji Hospital, Tongji University School of Medicine, Shanghai, China
6 shared publications- Hubin Duan
The Eleventh Clinical College of Shanxi Medical University Lvliang
4 shared publications Xiaoxiao Song
Department of Pediatrics, Tongji Hospital, Tongji University School of Medicine, Shanghai, China
4 shared publications- Chunyan Hao
Guangdong University of Technology
3 shared publications Ning Zhou
Department of Pediatrics, Tongji Hospital, Tongji University School of Medicine, Shanghai, China
3 shared publications- Xue Wen
The Eleventh Clinical College of Shanxi Medical University Lvliang
3 shared publications
Latest Publications
- Open Access
Infection-Related Adverse Events of Tisagenlecleucel in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: A FAERS Pharmacovigilance Study
Background: Tisagenlecleucel (tis-cel) is the sole chimeric antigen receptor T-cell (CAR-T) therapy approved for pediatric/adolescent relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL). Infection-related adverse events (IRAEs) represent a leading cause of non-relapse mortality, yet dedicated analysis in patients p < 0.001). Most infections (93.86%) occurred within one month (median time-to-onset = 4 days), peaking within 15 days (77.50%); 2.65% occurred after one year. Significant disproportionate reporting signals were observed for Clostridioides difficile (ROR025 = 5.45), influenza virus (ROR025 = 7.16), and adenovirus (ROR025 = 3.51). Hypogammaglobulinemia (52.94%) and hypoxia (54.90%) exhibited higher co-occurrence with infections than CAR-T-specific toxicities (23.08–35.41%). Conclusions: Infection-related AEs following tis-cel treatment are frequent and associated with significantly increased mortality in pediatric and adolescent r/r B-ALL patients. While most occur early, late infections warrant long-term vigilance. Disproportionality analyses identified signals suggestive of potential high-risk pathogens such as Clostridioides difficile,, influenza, and adenovirus, and hypogammaglobulinemia/hypoxia may serve as early warning indicators. These hypothesis-generating findings require validation in prospective studies.
Open AccessInfection-Related Adverse Events of Tisagenlecleucel in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: A FAERS Pharmacovigilance Study
Background: Tisagenlecleucel (tis-cel) is the sole chimeric antigen receptor T-cell (CAR-T) therapy approved for pediatric/adolescent relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL). Infection-related adverse events (IRAEs) represent a leading cause of non-relapse mortality, yet dedicated analysis in patients p < 0.001). Most infections (93.86%) occurred within one month (median time-to-onset = 4 days), peaking within 15 days (77.50%); 2.65% occurred after one year. Significant disproportionate reporting signals were observed for Clostridioides difficile (ROR025 = 5.45), influenza virus (ROR025 = 7.16), and adenovirus (ROR025 = 3.51). Hypogammaglobulinemia (52.94%) and hypoxia (54.90%) exhibited higher co-occurrence with infections than CAR-T-specific toxicities (23.08–35.41%). Conclusions: Infection-related AEs following tis-cel treatment are frequent and associated with significantly increased mortality in pediatric and adolescent r/r B-ALL patients. While most occur early, late infections warrant long-term vigilance. Disproportionality analyses identified signals suggestive of potential high-risk pathogens such as Clostridioides difficile,, influenza, and adenovirus, and hypogammaglobulinemia/hypoxia may serve as early warning indicators. These hypothesis-generating findings require validation in prospective studies.
- Open Access
- 19 February 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Comparison of severe and general Mycoplasma pneumoniae pneumonia in children: a targeted next-generation sequencing based study
The incidence and severity of Mycoplasma pneumoniae pneumonia (MPP) in children have increased after the pandemic of COVID-19, raising public concern. Howe
- 19 February 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessComparison of severe and general Mycoplasma pneumoniae pneumonia in children: a targeted next-generation sequencing based study
The incidence and severity of Mycoplasma pneumoniae pneumonia (MPP) in children have increased after the pandemic of COVID-19, raising public concern. Howe
- Open Access
- 11 January 2026
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 20 (1)
Rhabdomyolysis due to influenza A and respiratory syncytial virus co-infection: a case report
Rhabdomyolysis is a rare but potentially life-threatening condition characterized by muscle necrosis and the release of intracellular contents into the blo
- 11 January 2026
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 20 (1)
Open AccessRhabdomyolysis due to influenza A and respiratory syncytial virus co-infection: a case report
Rhabdomyolysis is a rare but potentially life-threatening condition characterized by muscle necrosis and the release of intracellular contents into the blo
- Open Access
- 16 October 2024
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-10
New-generation tetracyclines for severe macrolide-resistant Mycoplasma pneumoniae pneumonia in children: a retrospective analysis
Background: Macrolide-resistant Mycoplasma pneumoniae (MRMP) strains are increasingly prevalent, leading to a rise in severe Mycoplasma pneumoniae pneumonia incidence annually, which poses a significant threat to children’s health. This study aimed to compare the effectiveness and safety of oral minocycline and doxycycline for the treatment of severe MRMP pneumonia in children. Methods: This retrospective analysis included children treated for severe MRMP pneumonia at the Pediatric Department of Tongji Hospital, Shanghai, China, between September 2023 and January 2024 using minocycline and doxycycline. The patients were divided into four groups according to treatment: oral doxycycline alone (DOX group), oral minocycline alone (MIN group), oral doxycycline with intravenous glucocorticoids (DOXG group), and oral minocycline with intravenous glucocorticoids (MING group). Student’s t-test, Mann–Whitney U test, and χ2 or Fisher’s exact tests were used for group comparisons. Results: A total of 165 patients were included in this study: 84 received minocycline, and 81 received doxycycline. The DOX group had higher fever resolution rates within 24, 48, and 72 h compared to the MIN group (63.2% vs. 31.8%, 79.0% vs. 63.6%, and 100% vs. 90.9%, respectively; all p < 0.05). The DOXG group showed higher fever resolution rates within 24 and 48 h than the MING group (92.3% vs. 83.4%, 100% vs. 92.7%, all p > 0.05). There were no statistically significant differences in time to imaging improvement, cough improvement, and disappearance of wet rales between groups, regardless of glucocorticoid combination. The longer the duration of fever prior to tetracycline therapy, the greater the likelihood of hypoxemia (p = 0.039) and a greater than two-fold elevation in the D-dimer level (p = 0.004).Univariate binary logistic regression model analysis revealed that CRP and erythrocyte sedimentation rate at disease onset were associated with defervescence within 24 h after treatment with tetracyclines alone (p = 0.020, p = 0.027), with erythrocyte sedimentation rate also influencing defervescence within 48 h (p = 0.022). Conclusion: Doxycycline treatment resulted in a higher rate of defervescence than minocycline. Prompt treatment reduced the probability of pleural effusion, hypoxemia, pulmonary atelectasis, and D-dimer levels > 2 times the reference value.
- 16 October 2024
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-10
Open AccessNew-generation tetracyclines for severe macrolide-resistant Mycoplasma pneumoniae pneumonia in children: a retrospective analysis
Background: Macrolide-resistant Mycoplasma pneumoniae (MRMP) strains are increasingly prevalent, leading to a rise in severe Mycoplasma pneumoniae pneumonia incidence annually, which poses a significant threat to children’s health. This study aimed to compare the effectiveness and safety of oral minocycline and doxycycline for the treatment of severe MRMP pneumonia in children. Methods: This retrospective analysis included children treated for severe MRMP pneumonia at the Pediatric Department of Tongji Hospital, Shanghai, China, between September 2023 and January 2024 using minocycline and doxycycline. The patients were divided into four groups according to treatment: oral doxycycline alone (DOX group), oral minocycline alone (MIN group), oral doxycycline with intravenous glucocorticoids (DOXG group), and oral minocycline with intravenous glucocorticoids (MING group). Student’s t-test, Mann–Whitney U test, and χ2 or Fisher’s exact tests were used for group comparisons. Results: A total of 165 patients were included in this study: 84 received minocycline, and 81 received doxycycline. The DOX group had higher fever resolution rates within 24, 48, and 72 h compared to the MIN group (63.2% vs. 31.8%, 79.0% vs. 63.6%, and 100% vs. 90.9%, respectively; all p < 0.05). The DOXG group showed higher fever resolution rates within 24 and 48 h than the MING group (92.3% vs. 83.4%, 100% vs. 92.7%, all p > 0.05). There were no statistically significant differences in time to imaging improvement, cough improvement, and disappearance of wet rales between groups, regardless of glucocorticoid combination. The longer the duration of fever prior to tetracycline therapy, the greater the likelihood of hypoxemia (p = 0.039) and a greater than two-fold elevation in the D-dimer level (p = 0.004).Univariate binary logistic regression model analysis revealed that CRP and erythrocyte sedimentation rate at disease onset were associated with defervescence within 24 h after treatment with tetracyclines alone (p = 0.020, p = 0.027), with erythrocyte sedimentation rate also influencing defervescence within 48 h (p = 0.022). Conclusion: Doxycycline treatment resulted in a higher rate of defervescence than minocycline. Prompt treatment reduced the probability of pleural effusion, hypoxemia, pulmonary atelectasis, and D-dimer levels > 2 times the reference value.
- Open Access
Post-Pandemic Epidemiology of Respiratory Infections among Pediatric Inpatients in a Tertiary Hospital in Shanghai, China
Background: After the removal of the three-year epidemic control restrictions, Chinese children were confronted with heightened risks of respiratory infections. We aimed to investigate the post-pandemic (2023) epidemiology of respiratory infections among pediatric inpatients in a tertiary hospital in Shanghai, China, and compare it with the pre-pandemic (2019) levels. Methods: A total of 2644 pediatric inpatients were enrolled based on discharge time and divided into group 2019 (n = 1442) and group 2023 (n = 1202). Information on the demographic characteristics, diagnoses, and pathogen test results (Mycoplasma pneumoniae, MP; Chlamydia pneumoniae, CP; Legionella pneumophila, LP; Influenza A, IFA; Influenza B, IFB; Parainfluenza virus, PIV; respiratory syncytial virus, RSV; Coxsackie virus, COX; Adenovirus, ADV; Epstein–Barr virus, EBV) was collected and analyzed. Results: Significant increases were found in the overall test positivity rates (64.6% vs. 46.7%), mixed infection rates (17.4% vs. 9%), and proportion of severe cases (25.5% vs. 3.7%) after the pandemic than those before it. Compared with 2019, the incidences of MP, IFA, LP, RSV, and ADV remarkably increased, while those of IFB and COX decreased, with no obvious differences noted for CP, PIV, and EBV in 2023. A significantly higher MP-positive detection rate was noticed in children aged 1–6 years in 2023 than in 2019. The incidence of RSV infection began to rise in August 2023, earlier than the conventional epidemic season. Conclusions: Compared with the pre-pandemic levels, the overall test positivity rates of atypical pathogens and viruses among pediatric inpatients significantly increased, and alterations in the disease spectrum, epidemic season, and age of prevalence were observed after the COVID-19 pandemic.
Open AccessPost-Pandemic Epidemiology of Respiratory Infections among Pediatric Inpatients in a Tertiary Hospital in Shanghai, China
Background: After the removal of the three-year epidemic control restrictions, Chinese children were confronted with heightened risks of respiratory infections. We aimed to investigate the post-pandemic (2023) epidemiology of respiratory infections among pediatric inpatients in a tertiary hospital in Shanghai, China, and compare it with the pre-pandemic (2019) levels. Methods: A total of 2644 pediatric inpatients were enrolled based on discharge time and divided into group 2019 (n = 1442) and group 2023 (n = 1202). Information on the demographic characteristics, diagnoses, and pathogen test results (Mycoplasma pneumoniae, MP; Chlamydia pneumoniae, CP; Legionella pneumophila, LP; Influenza A, IFA; Influenza B, IFB; Parainfluenza virus, PIV; respiratory syncytial virus, RSV; Coxsackie virus, COX; Adenovirus, ADV; Epstein–Barr virus, EBV) was collected and analyzed. Results: Significant increases were found in the overall test positivity rates (64.6% vs. 46.7%), mixed infection rates (17.4% vs. 9%), and proportion of severe cases (25.5% vs. 3.7%) after the pandemic than those before it. Compared with 2019, the incidences of MP, IFA, LP, RSV, and ADV remarkably increased, while those of IFB and COX decreased, with no obvious differences noted for CP, PIV, and EBV in 2023. A significantly higher MP-positive detection rate was noticed in children aged 1–6 years in 2023 than in 2019. The incidence of RSV infection began to rise in August 2023, earlier than the conventional epidemic season. Conclusions: Compared with the pre-pandemic levels, the overall test positivity rates of atypical pathogens and viruses among pediatric inpatients significantly increased, and alterations in the disease spectrum, epidemic season, and age of prevalence were observed after the COVID-19 pandemic.
- Open Access
Exploring the Genotype–Phenotype Correlations in a Child with Inherited Seizure and Thrombocytopenia by Digenic Network Analysis
Understanding the correlation between genotype and phenotype remains challenging for modern genetics. Digenic network analysis may provide useful models for understanding complex phenotypes that traditional Mendelian monogenic models cannot explain. Clinical data, whole exome sequencing data, in silico, and machine learning analysis were combined to construct a digenic network that may help unveil the complex genotype–phenotype correlations in a child presenting with inherited seizures and thrombocytopenia. The proband inherited a maternal heterozygous missense variant in SCN1A (NM_001165963.4:c.2722G>A) and a paternal heterozygous missense variant in MYH9 (NM_002473.6:c.3323A>C). In silico analysis showed that these two variants may be pathogenic for inherited seizures and thrombocytopenia in the proband. Moreover, focusing on 230 epilepsy-associated genes and 35 thrombopoiesis genes, variant call format data of the proband were analyzed using machine learning tools (VarCoPP 2.0) and Digenic Effect predictor. A digenic network was constructed, and SCN1A and MYH9 were found to be core genes in the network. Further analysis showed that MYH9 might be a modifier of SCN1A, and the variant in MYH9 might not only influence the severity of SCN1A-related seizure but also lead to thrombocytopenia in the bone marrow. In addition, another eight variants might also be co-factors that account for the proband’s complex phenotypes. Our data show that as a supplement to the traditional Mendelian monogenic model, digenic network analysis may provide reasonable models for the explanation of complex genotype–phenotype correlations.
Open AccessExploring the Genotype–Phenotype Correlations in a Child with Inherited Seizure and Thrombocytopenia by Digenic Network Analysis
Understanding the correlation between genotype and phenotype remains challenging for modern genetics. Digenic network analysis may provide useful models for understanding complex phenotypes that traditional Mendelian monogenic models cannot explain. Clinical data, whole exome sequencing data, in silico, and machine learning analysis were combined to construct a digenic network that may help unveil the complex genotype–phenotype correlations in a child presenting with inherited seizures and thrombocytopenia. The proband inherited a maternal heterozygous missense variant in SCN1A (NM_001165963.4:c.2722G>A) and a paternal heterozygous missense variant in MYH9 (NM_002473.6:c.3323A>C). In silico analysis showed that these two variants may be pathogenic for inherited seizures and thrombocytopenia in the proband. Moreover, focusing on 230 epilepsy-associated genes and 35 thrombopoiesis genes, variant call format data of the proband were analyzed using machine learning tools (VarCoPP 2.0) and Digenic Effect predictor. A digenic network was constructed, and SCN1A and MYH9 were found to be core genes in the network. Further analysis showed that MYH9 might be a modifier of SCN1A, and the variant in MYH9 might not only influence the severity of SCN1A-related seizure but also lead to thrombocytopenia in the bone marrow. In addition, another eight variants might also be co-factors that account for the proband’s complex phenotypes. Our data show that as a supplement to the traditional Mendelian monogenic model, digenic network analysis may provide reasonable models for the explanation of complex genotype–phenotype correlations.
- Open Access
- 6 October 2023
- Published by Springer Nature in BMC Pediatrics
- Vol. 23 (1) , 1-9
Clinical features, epidemiology, and treatment of Shwachman-Diamond syndrome: a systematic review
Background: Shwachman-Diamond syndrome (SDS) is an autosomal recessive disease which results in inherited bone marrow failure (IBMF) and is characterized by exocrine pancreatic dysfunction and diverse clinical phenotypes. In the present study, we reviewed the internationally published reports on SDS patients, in order to summarize the clinical features, epidemiology, and treatment of SDS. Methods: We searched the WangFang and China National Knowledge Infrastructure databases with the keywords “Shwachman-Diamond syndrome,” “SDS,” “SBDS gene” and “inherited bone marrow failure” for relevant articles published from January 2002 to October 2022. In addition, studies published from January 2002 to October 2022 were searched from the Web of Science, PubMed, and MEDLINE databases, using “Shwachman-diamond syndrome” as the keyword. Finally, one child with SDS treated in Tongji Hospital was also included. Results: The clinical features of 156 patients with SDS were summarized. The three major clinical features of SDS were found to be peripheral blood cytopenia (96.8%), exocrine pancreatic dysfunction (83.3%), and failure to thrive (83.3%). The detection rate of SDS mutations was 94.6% (125/132). Mutations in SBDS, DNAJC21, SRP54, ELF6, and ELF1 have been reported. The male-to-female ratio was approximately 1.3/1. The median age of onset was 0.16 years, but the diagnostic age lagged by a median age of 1.3 years. Conclusions: Pancreatic exocrine insufficiency and growth failure were common initial symptoms. SDS onset occurred early in childhood, and individual differences were obvious. Comprehensive collection and analysis of case-related data can help clinicians understand the clinical characteristics of SDS, which may improve early diagnosis and promote effective clinical intervention.
- 6 October 2023
- Published by Springer Nature in BMC Pediatrics
- Vol. 23 (1) , 1-9
Open AccessClinical features, epidemiology, and treatment of Shwachman-Diamond syndrome: a systematic review
Background: Shwachman-Diamond syndrome (SDS) is an autosomal recessive disease which results in inherited bone marrow failure (IBMF) and is characterized by exocrine pancreatic dysfunction and diverse clinical phenotypes. In the present study, we reviewed the internationally published reports on SDS patients, in order to summarize the clinical features, epidemiology, and treatment of SDS. Methods: We searched the WangFang and China National Knowledge Infrastructure databases with the keywords “Shwachman-Diamond syndrome,” “SDS,” “SBDS gene” and “inherited bone marrow failure” for relevant articles published from January 2002 to October 2022. In addition, studies published from January 2002 to October 2022 were searched from the Web of Science, PubMed, and MEDLINE databases, using “Shwachman-diamond syndrome” as the keyword. Finally, one child with SDS treated in Tongji Hospital was also included. Results: The clinical features of 156 patients with SDS were summarized. The three major clinical features of SDS were found to be peripheral blood cytopenia (96.8%), exocrine pancreatic dysfunction (83.3%), and failure to thrive (83.3%). The detection rate of SDS mutations was 94.6% (125/132). Mutations in SBDS, DNAJC21, SRP54, ELF6, and ELF1 have been reported. The male-to-female ratio was approximately 1.3/1. The median age of onset was 0.16 years, but the diagnostic age lagged by a median age of 1.3 years. Conclusions: Pancreatic exocrine insufficiency and growth failure were common initial symptoms. SDS onset occurred early in childhood, and individual differences were obvious. Comprehensive collection and analysis of case-related data can help clinicians understand the clinical characteristics of SDS, which may improve early diagnosis and promote effective clinical intervention.
- Open Access
- 7 April 2023
- Published by Springer Nature in Research Square
Clinical features of Shwachman-Diamond syndrome: A systematic review
Introduction Shwachman-Diamond syndrome (SDS) is an autosomal recessive inherited bone marrow failure (IBMF) with exocrine pancreatic dysfunction and diverse clinical phenotype. To summarize the clinical features, epidemiology and treatment of SDS, we reviewed internationally published reports of patients with SDS. Materials and methods With "Shwachman-Diamond syndrome", "SDS", "SBDS gene" and "inherited bone marrow failure" as keywords, the search period was setted from January 2002 to October 2022, and the relevant literatures of WangFang Database and China national knowledge infrastructure database was collected. In addition, using "Shwachman-diamond syndrome" as the keyword, literature reports from Web of Science, PubMed, and MEDLINE databases from January 2002 to October 2022 were retrieved, and a child with SDS treated in Tongji Hospital was also included. Results The clinical features of 156 SDS patients were summarized. Three major SDS clinical features were cytopenia (94%), exocrine pancreatic dysfunction (83%), and failure to thrive (83%). The detection rate of SDS gene mutation was 94.6% (125/132). Mutations in SBDS, DNAJC21, SRP54, ELF6 and ELF1 genes have been reported. The male to female ratio is about 1.3/1. The median age at onset was 1.9 months, but the median age at diagnosis was 15.6 months. Conclusion Common initial symptoms were pancreatic exocrine insufficiency and growth failure. The onset age of SDS in children is early and the individual difference is obvious. Comprehensively collecting and analyzing case related data can help clinicians understand the clinical characteristics of SDS, which may improve early diagnosis and effective clinical intervention of SDS.
- 7 April 2023
- Published by Springer Nature in Research Square
Open AccessClinical features of Shwachman-Diamond syndrome: A systematic review
Introduction Shwachman-Diamond syndrome (SDS) is an autosomal recessive inherited bone marrow failure (IBMF) with exocrine pancreatic dysfunction and diverse clinical phenotype. To summarize the clinical features, epidemiology and treatment of SDS, we reviewed internationally published reports of patients with SDS. Materials and methods With "Shwachman-Diamond syndrome", "SDS", "SBDS gene" and "inherited bone marrow failure" as keywords, the search period was setted from January 2002 to October 2022, and the relevant literatures of WangFang Database and China national knowledge infrastructure database was collected. In addition, using "Shwachman-diamond syndrome" as the keyword, literature reports from Web of Science, PubMed, and MEDLINE databases from January 2002 to October 2022 were retrieved, and a child with SDS treated in Tongji Hospital was also included. Results The clinical features of 156 SDS patients were summarized. Three major SDS clinical features were cytopenia (94%), exocrine pancreatic dysfunction (83%), and failure to thrive (83%). The detection rate of SDS gene mutation was 94.6% (125/132). Mutations in SBDS, DNAJC21, SRP54, ELF6 and ELF1 genes have been reported. The male to female ratio is about 1.3/1. The median age at onset was 1.9 months, but the median age at diagnosis was 15.6 months. Conclusion Common initial symptoms were pancreatic exocrine insufficiency and growth failure. The onset age of SDS in children is early and the individual difference is obvious. Comprehensively collecting and analyzing case related data can help clinicians understand the clinical characteristics of SDS, which may improve early diagnosis and effective clinical intervention of SDS.
- Open Access
- 14 May 2021
- Published by Wiley in The FASEB Journal
- Vol. 35 (S1)
Effect of Ginkgo biloba leaf extract on serum nuclear factor‐κB content and intracellular calcium concentration after traumatic spinal cord injury
Objective: To study the effects of Ginkgo biloba leaf extract on serum nuclear factor‐κB(NF‐κB) content and intracellular calcium ion concentration after traumatic spinal cord injury. Methods: Forty‐two SD rats were randomly divided into three groups: sham operation group (group S), trauma group (group T) and ginkgo biloba extract intervention group (group G), with an average of 14 rats in each group, The weight of the rat was 200±20g. Rats model of spinal cord injury was established in accordance with the model of Allen's hit. Rats in group G were intraperitoneally injected with Ginkgo biloba extract 100mg/kg every day for 3 consecutive days after injury. Group S and group T were given intraperitoneal injection of the same dose of normal saline. On day 4, the rats were sacrificed and the spinal cord tissues were taken out after blood collection. The calcium content of spinal cord cells was detected by laser scanning confocal microscopy, and the serum NF‐κB concentration was determined by enzyme linked immunosorbent assay(ELISA). Results: The calcium fluorescence intensity of spinal cord cells in the group S, group T and group G) had statistical significance ( P P <0.05). The highest in group T, followed by group G, and the lowest in group S. Conclusion: Ginkgo biloba leaf extract can reduce the content of nuclear factor‐κB in serum and the concentration of calcium ions in spinal cord cells after traumatic spinal cord injury, reduce inflammation and calcium overload, and then might reduce the occurrence of spinal cord cell injury and edema.
- 14 May 2021
- Published by Wiley in The FASEB Journal
- Vol. 35 (S1)
Open AccessEffect of Ginkgo biloba leaf extract on serum nuclear factor‐κB content and intracellular calcium concentration after traumatic spinal cord injury
Objective: To study the effects of Ginkgo biloba leaf extract on serum nuclear factor‐κB(NF‐κB) content and intracellular calcium ion concentration after traumatic spinal cord injury. Methods: Forty‐two SD rats were randomly divided into three groups: sham operation group (group S), trauma group (group T) and ginkgo biloba extract intervention group (group G), with an average of 14 rats in each group, The weight of the rat was 200±20g. Rats model of spinal cord injury was established in accordance with the model of Allen's hit. Rats in group G were intraperitoneally injected with Ginkgo biloba extract 100mg/kg every day for 3 consecutive days after injury. Group S and group T were given intraperitoneal injection of the same dose of normal saline. On day 4, the rats were sacrificed and the spinal cord tissues were taken out after blood collection. The calcium content of spinal cord cells was detected by laser scanning confocal microscopy, and the serum NF‐κB concentration was determined by enzyme linked immunosorbent assay(ELISA). Results: The calcium fluorescence intensity of spinal cord cells in the group S, group T and group G) had statistical significance ( P P <0.05). The highest in group T, followed by group G, and the lowest in group S. Conclusion: Ginkgo biloba leaf extract can reduce the content of nuclear factor‐κB in serum and the concentration of calcium ions in spinal cord cells after traumatic spinal cord injury, reduce inflammation and calcium overload, and then might reduce the occurrence of spinal cord cell injury and edema.
- Open Access
- 14 May 2021
- Published by Wiley in The FASEB Journal
- Vol. 35 (S1)
Effects of SV2B on proliferation, invasion and migration of human glioma cells
Objective: To study the effects of synaptic vesicle glycoprotein 2B(SV2B) on proliferation, invasion and migration of human glioma cells. Methods: Bioinformatics analysis of the prognosis of malignant glioma related genes, and to establish a stable expression SV2B cell line U251 and U87, using the fluorescence microscope and image cells infected with fluorescence efficiency, further extraction cell protein and Westblot experiment, testing each SV2B protein expression, scratch test each cell migration ability, Transwell migration experiment testing each cell migration ability, Transwell invasion experiment testing each cell invasive, EdU experiment testing each cell proliferation, The cell proliferation ability was detected by plate colony formation assay. Results: Bioinformatics analysis showed that SV2B was a gene associated with poor prognosis in glioma, and high expression of SV2B protein was associated with shorter survival time in GBM patients. In the stably expressing SV2B cell lines constructed by lentivirus, overexpression of SV2B family caused the enhancement of proliferation, invasion and migration of human glioma cells. Conclusion: SV2B plays an important role in proliferation, invasion and migration of human glioma cells.
- 14 May 2021
- Published by Wiley in The FASEB Journal
- Vol. 35 (S1)
Open AccessEffects of SV2B on proliferation, invasion and migration of human glioma cells
Objective: To study the effects of synaptic vesicle glycoprotein 2B(SV2B) on proliferation, invasion and migration of human glioma cells. Methods: Bioinformatics analysis of the prognosis of malignant glioma related genes, and to establish a stable expression SV2B cell line U251 and U87, using the fluorescence microscope and image cells infected with fluorescence efficiency, further extraction cell protein and Westblot experiment, testing each SV2B protein expression, scratch test each cell migration ability, Transwell migration experiment testing each cell migration ability, Transwell invasion experiment testing each cell invasive, EdU experiment testing each cell proliferation, The cell proliferation ability was detected by plate colony formation assay. Results: Bioinformatics analysis showed that SV2B was a gene associated with poor prognosis in glioma, and high expression of SV2B protein was associated with shorter survival time in GBM patients. In the stably expressing SV2B cell lines constructed by lentivirus, overexpression of SV2B family caused the enhancement of proliferation, invasion and migration of human glioma cells. Conclusion: SV2B plays an important role in proliferation, invasion and migration of human glioma cells.